Metabolomics and cardiovascular risk factors in autoimmune-mediated connective tissue diseases - an exploratory, hypothesis-generating study.

IF 3.1 Q3 RHEUMATOLOGY
Emily Deichsler, Steffen Heelemann, Selina Strathmeyer, Meike Hoffmeister, Werner Dammermann, Oliver Ritter, Daniel Patschan, Susann Patschan
{"title":"Metabolomics and cardiovascular risk factors in autoimmune-mediated connective tissue diseases - an exploratory, hypothesis-generating study.","authors":"Emily Deichsler, Steffen Heelemann, Selina Strathmeyer, Meike Hoffmeister, Werner Dammermann, Oliver Ritter, Daniel Patschan, Susann Patschan","doi":"10.1186/s41927-026-00670-8","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Autoimmune connective tissue diseases (ACTD), including systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjögren's disease (SD), and idiopathic inflammatory myopathies (IIM), are associated with markedly increased cardiovascular risk (CVR) that is insufficiently captured by conventional risk scores. Reliable biomarkers for CVR stratification in ACTD are lacking. This exploratory, hypothesis-generatig study aimed to investigate whether metabolomic alterations reflect CVR across ACTD subtypes.</p><p><strong>Methods: </strong>In this cross-sectional, exploratory study, patients with SLE (n = 33), SSc (n = 18), SD (n = 16), and IIM (n = 9) were recruited from a tertiary rheumatology center. Serum metabolomic profiling was performed using ¹H-NMR spectroscopy. Associations between 113 quantified metabolites and clinical CVR parameters (including age, sex, body mass index, glucocorticoid use, Framingham score, hypertension, diabetes, lipid parameters, and lifestyle factors) were analyzed using non-parametric statistics with false discovery rate correction. Correlation analyses were conducted using Spearman coefficients.</p><p><strong>Results: </strong>Metabolomic alterations varied substantially across ACTD subtypes and CVR factors. Lipid metabolites showed the strongest and most consistent associations with CVR parameters. The Framingham score correlated with 11 metabolites in SLE, 1 in SSc, 2 in SD, and 93 in IIM, predominantly involving lipid components. Diabetes mellitus was associated with extensive metabolomic changes, particularly in SSc (n = 62 metabolites), followed by SD (n = 20) and SLE (n = 5). In contrast, arterial hypertension showed minimal metabolomic differentiation across most ACTD, except in IIM. Body mass index correlated mainly with lipid metabolites in SSc, but not in SLE. Glucocorticoid therapy and dosage were strongly associated with alterations in lipid metabolism, especially in SLE and SSc. Across all entities, correlations with total cholesterol, LDL, and HDL were dominated by lipid metabolites. Associations with renal markers (UACR) were limited.</p><p><strong>Conclusions: </strong>ACTD are characterized by heterogeneous metabolomic signatures associated with cardiovascular risk factors. Larger, longitudinal studies are required to validate these findings and to determine their clinical utility in cardiovascular risk stratification in ACTD.</p>","PeriodicalId":9150,"journal":{"name":"BMC Rheumatology","volume":"10 1","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2026-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13326006/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Rheumatology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s41927-026-00670-8","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RHEUMATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Autoimmune connective tissue diseases (ACTD), including systemic lupus erythematosus (SLE), systemic sclerosis (SSc), Sjögren's disease (SD), and idiopathic inflammatory myopathies (IIM), are associated with markedly increased cardiovascular risk (CVR) that is insufficiently captured by conventional risk scores. Reliable biomarkers for CVR stratification in ACTD are lacking. This exploratory, hypothesis-generatig study aimed to investigate whether metabolomic alterations reflect CVR across ACTD subtypes.

Methods: In this cross-sectional, exploratory study, patients with SLE (n = 33), SSc (n = 18), SD (n = 16), and IIM (n = 9) were recruited from a tertiary rheumatology center. Serum metabolomic profiling was performed using ¹H-NMR spectroscopy. Associations between 113 quantified metabolites and clinical CVR parameters (including age, sex, body mass index, glucocorticoid use, Framingham score, hypertension, diabetes, lipid parameters, and lifestyle factors) were analyzed using non-parametric statistics with false discovery rate correction. Correlation analyses were conducted using Spearman coefficients.

Results: Metabolomic alterations varied substantially across ACTD subtypes and CVR factors. Lipid metabolites showed the strongest and most consistent associations with CVR parameters. The Framingham score correlated with 11 metabolites in SLE, 1 in SSc, 2 in SD, and 93 in IIM, predominantly involving lipid components. Diabetes mellitus was associated with extensive metabolomic changes, particularly in SSc (n = 62 metabolites), followed by SD (n = 20) and SLE (n = 5). In contrast, arterial hypertension showed minimal metabolomic differentiation across most ACTD, except in IIM. Body mass index correlated mainly with lipid metabolites in SSc, but not in SLE. Glucocorticoid therapy and dosage were strongly associated with alterations in lipid metabolism, especially in SLE and SSc. Across all entities, correlations with total cholesterol, LDL, and HDL were dominated by lipid metabolites. Associations with renal markers (UACR) were limited.

Conclusions: ACTD are characterized by heterogeneous metabolomic signatures associated with cardiovascular risk factors. Larger, longitudinal studies are required to validate these findings and to determine their clinical utility in cardiovascular risk stratification in ACTD.

自身免疫介导的结缔组织疾病的代谢组学和心血管危险因素——一项探索性的、产生假设的研究
背景:自身免疫性结缔组织疾病(ACTD),包括系统性红斑狼疮(SLE)、系统性硬化症(SSc)、Sjögren病(SD)和特发性炎性肌病(IIM),与心血管风险(CVR)显著增加相关,而传统的风险评分无法充分捕捉到这一点。缺乏可靠的ACTD CVR分层生物标志物。这项探索性的、产生假设的研究旨在调查代谢组学改变是否反映了ACTD亚型的CVR。方法:在这项横断面探索性研究中,从三级风湿病中心招募SLE (n = 33)、SSc (n = 18)、SD (n = 16)和IIM (n = 9)患者。采用¹H-NMR谱法进行血清代谢组学分析。采用非参数统计分析113种量化代谢物与临床CVR参数(包括年龄、性别、体重指数、糖皮质激素使用、Framingham评分、高血压、糖尿病、脂质参数和生活方式因素)之间的相关性,并校正错误发现率。采用Spearman系数进行相关分析。结果:代谢组学改变在ACTD亚型和CVR因素之间有很大差异。脂质代谢物与CVR参数的相关性最强且最一致。Framingham评分与SLE患者的11种代谢物、SSc患者的1种代谢物、SD患者的2种代谢物和IIM患者的93种代谢物相关,主要涉及脂质成分。糖尿病与广泛的代谢组学变化相关,尤其是SSc (n = 62),其次是SD (n = 20)和SLE (n = 5)。相比之下,动脉高血压在大多数ACTD中表现出最小的代谢组分化,除了IIM。体重指数主要与SSc的脂质代谢物相关,而与SLE无关。糖皮质激素治疗和剂量与脂质代谢的改变密切相关,尤其是SLE和SSc。在所有实体中,与总胆固醇、低密度脂蛋白和高密度脂蛋白的相关性以脂质代谢物为主。与肾脏标志物(UACR)的关联有限。结论:ACTD具有与心血管危险因素相关的异质性代谢组学特征。需要更大规模的纵向研究来验证这些发现,并确定其在ACTD心血管风险分层中的临床应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BMC Rheumatology
BMC Rheumatology Medicine-Rheumatology
CiteScore
3.80
自引率
0.00%
发文量
73
审稿时长
15 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书